Clinical challenges and technological breakthroughs in helminthic therapy for diabetes

Area of Science:

• Immunology
• Metabolic Disorders
• Microbiome Research

Background:

• Helminthic therapy is an emerging strategy for Diabetes Mellitus (DM).
• It modulates host immune and metabolic systems, enhancing insulin sensitivity and reducing inflammation.
• Risks like infections necessitate safer therapeutic methods.

Purpose of the Study:

• To comprehensively evaluate the mechanisms, clinical outcomes, and safety improvement strategies of helminthic therapy for DM.
• To propose advanced strategies for safe and precise application of helminthic therapy.
• To develop a clinical decision-making framework for helminthic therapy in diabetic patients.

Main Methods:

• Systematic review following PRISMA guidelines.
• Analysis of 163 high-quality studies from PubMed, Web of Science, and Scopus.
• Evaluation of mechanisms, clinical outcomes, and safety enhancement strategies.

Main Results:

• Helminthic therapy alleviates hyperglycemia, chronic inflammation, and insulin resistance in diabetic patients.
• The therapy offers substantial health benefits via immunomodulatory and metabolic effects.
• Proposed strategies include genetic editing, real-time monitoring, and helminth-derived molecules for safety.

Conclusions:

• Helminthic therapy demonstrates significant potential as a revolutionary treatment for Diabetes Mellitus.
• A detailed clinical decision-making framework is proposed for safe and effective application.
• Further development of precision strategies is crucial for widespread adoption.